• Travere Therapeutics granted inducement equity awards covering 48,800 common shares to four newly hired employees on May 10, 2026.
• Awards comprised non-qualified stock options for 18,000 shares with a $43.51 exercise price, 10-year term, 25% cliff vest at one year, remaining vest monthly over 36 months.
• Restricted stock units covered 30,800 shares, vesting 25% on each anniversary over four years.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Travere Therapeutics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260512102473) on May 12, 2026, and is solely responsible for the information contained therein.